Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs SBAC✓SelectedUSD · SBACMRNA vs SBAC performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs SBAC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+336.0%
SBAC return
-14.9%
Excess return
+350.9%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioSBACExcessAlpha
1D+1.3%-2.2%+3.5%+2.1%
7D-13.8%-9.1%-4.8%-10.9%
30D-17.7%-5.6%-12.0%-15.2%
3M+14.3%-5.7%+20.0%+17.9%
6M+336.0%-16.6%+352.6%+340.8%
All+336.0%-14.9%+350.9%+340.8%

Cumulative growth

Daily Returns

Daily percentage return beside SBAC.

Daily Out/Under-Performance

Portfolio return minus SBAC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling